Compositions for the treatment of gastrointestinal inflammation

Details for Australian Patent Application No. 2008321030 (hide)

Owner Meritage Pharma, Inc.

Inventors Hill, Malcolm; Phillips, Elaine

Agent Shelston IP

Pub. Number AU-A-2008321030

PCT Pub. Number WO2009/064819

Priority 61/034,941 07.03.08 US; 60/987,720 13.11.07 US; 61/090,568 20.08.08 US; 61/015,998 21.12.07 US; 61/019,818 08.01.08 US; 61/035,348 10.03.08 US; 61/054,107 16.05.08 US; 61/054,103 16.05.08 US; 61/012,012 06.12.07 US; 61/054,105 16.05.08 US; 61/054,104 16.05.08 US; 61/054,106 16.05.08 US

Filing date 12 November 2008

Wipo publication date 22 May 2009

International Classifications

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61K 38/35 (2006.01) Medicinal preparations containing peptides

A61P 1/14 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/064819 Priority application(s): WO2009/064819

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008321046-4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-ami nes as janus kinase inhibitors

2008321027-Processes for rapid microfabrication using thermoplastics and devices thereof